Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Medlife Pharmacy and Compounding
483
•Medlife Pharmacy and Compounding•April 18, 2018

Medlife Pharmacy and Compounding – FDA 483, Apr 18, 2018

Record Details

During an FDA inspection conducted from April 9 to April 18, 2018, Medlife Pharmacy and Compounding, a producer of non-sterile drugs, received ten significant observations. The firm was cited for critical deficiencies related to its production and quality control systems, indicating potential non-compliance with current Good Manufacturing Practices (cGMP).

Key violations included the absence of a written stability testing program, leading to unsupported expiration dates for drug products. The facility demonstrated inadequate separation and control systems, risking cross-contamination between potent and non-potent compounds due to shared equipment in a single production hood. Additionally, the inspection revealed a lack of procedures to prevent microbiological contamination for drugs purported to be sterile, and a failure to perform essential microbial and potency testing on both components and finished products before release.

The firm also lacked proper record-keeping for equipment cleaning and maintenance. Furthermore, critical instruments, such as micro-analytical balances and thermometers, were either uncalibrated or had expired calibrations. Utensils and containers were inadequately cleaned, using only tap water, further compromising product quality and safety. Medlife Pharmacy is required to address these observations by implementing corrective actions to ensure compliance with regulatory standards.

Company
Medlife Pharmacy and Compounding
Inspection date
April 18, 2018
Product type
Drugs
Office
Los Angeles District Office
Person
  • Yasamin Ameri (Compliance Officer)
View Company Profile

ID · 67975b68-660b-4396-a94e-a7607bf7a294

Violation Codes3
21 CFR 21021 CFR 21121 U.S.C. 331(c)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Medlife Pharmacy and Compounding
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.